GlassScriptPhysician profile
Thomas A D Amico
NPI 1023171899
$94,065.94
in general payments reported to CMS, 2019-2025
10 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70K · 2020: $15K · 2021: $134 · 2022: $3,720 · 2023: $3,374 · 2024: $1,374 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,575 · Grant: $1,495 · Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,574.88 |
| Grant | $1,494.51 |
| Food and Beverage | $811.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $46,624.38 | 2019 | |
| Scanlan International INC | $36,342.46 | 2019-2020 | |
| Medtronic, INC. | $7,097.08 | 2021-2025 | Endo Gia Ultra, Signia, Illumisite |
| Medical Device Business Services, INC. | $1,374.02 | 2024 | Echelon Flex |
| E.R. Squibb & Sons, L.L.C. | $1,280.00 | 2019 | |
| Surgical Theater. INC. | $965.01 | 2020 | |
| Karl Storz Endoscopy-America | $119.61 | 2019 | |
| Genentech USA, INC. | $117.04 | 2022 | |
| Stryker Corporation | $112.63 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $33.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas D Amico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.